Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Keryx Biopharm Inc (KERX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2007	12-2006	12-2005	12-2004	12-2003
Assets
Current Assets
Cash & Cash Equivalents	19,065	48,736	68,175	29,699	21,672
Marketable Securities	43,038	63,659	18,272	20,035	9,631
Receivables	283	525	3,536	766	324
Other current assets	1,344	2,048	0	0	352
TOTAL	$63,730	$114,968	$89,983	$50,500	$31,979

Non-Current Assets
PPE Net	11,483	8,489	1,004	145	24
Investments And Advances	2,296	12,690	13,950	0	0
Intangibles	3,208	3,208	0	0	0
Other Non-Current Assets	344	958	160	217	220
TOTAL	$17,331	$25,345	$15,114	$362	$244

Total Assets	$81,061	$140,313	$105,097	$50,862	$32,223

Liabilities
Current Liabilities
Accounts payable and accrued liabilities	18,971	10,460	5,054	3,079	894
Accrued Expenses	1,254	1,534	936	743	103
TOTAL	$21,411	$12,194	$6,093	$3,962	$997

Non-Current Liabilities
Deferred Revenues	1,023	200	103	140	N/A
Other Non-Current Liabilities	4,206	4,298	4,326	4,096	0
TOTAL	$15,228	$4,298	$4,326	$4,096	$N/A

Total Liabilities	$36,639	$16,492	$10,419	$8,058	$997

Shareholders' Equity
Shares Outstanding, K	43,746	43,518	37,962	31,504	29,935
Common Shares	44	44	38	31	25
Retained earnings	-279,037	-188,212	-114,448	-87,553	-54,610
Other shareholders' equity	-357	-89	-89	-2,317	-231
TOTAL	$44,422	$123,821	$94,678	$42,804	$31,226

Total Liabilities And Equity	$81,061	$140,313	$105,097	$50,862	$32,223